Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Jure Murgić

34268

Jure

Murgić

dr. sc.

nije evidentirano
Naziv Akcije
Brčić, Hrvoje; Lekić, Mirela; Jazvić, Marijana; Murgić, Jure; Miletić, Marija; Prgomet Sečan, Angela; Tomašković, Igor; Hrkać, Adelina; Bokarica, Pero; Kaučić, Hrvoje et al. Stereotactic body radiation therapy in patients with advanced urothelial cancer treated with immunotherapy: early experience within croatian oncology referral network // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 83-84
Murgić, Jure; Jazvić, Marijana; Miletić, Marija; Prgomet Sečan, Angela; Ulamec, Monika; Vilović, Katarina; Pezelj, Ivan; Tomašković, Igor; Bokarica, Pero; Saratlija Novaković, Žana et al. Pathological downstaging, disease control and survival after neoadjuvant chemotherapy for bladder cancer in Croatia; a real-world study // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 73-74
Miletić, Marija; Brčić, Hrvoje; Prgomet Sečan, Angela; Franceschi, Dora; Šambić Penc, Mirela; Boraska Jelavić, Tihana; Murgić, Jure; Jazvić, Marijana; Komić, Dubravka; Omrčen,Tomislav et al. Dynamics of neutrophil-to-lymphocyte ratio as a biomarker of clinical response to immune checkpoint inhibitor therapy in a multicenter cohort of patients with advanced urothelial cancer within Croatian genitourinary cancer network // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 64-65
Vrljičak, Antonela; Murgić, Jure; Jakšić, Blanka; Prpić, Marin; Prgomet Sečan, Angela; Huić, Drazen; Fröbe, Ana; p2 – 68Ga PSMA PET/CT in patients with recurrent prostate cancer relapsing after primary treatment: initial single institution utility analysis // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 48-49
Bakaloudi, Dimitra Rafailia ; [...] ; Murgić, Jure; Miletić, Marija; Fröbe, Ana; [...] ; Grivas, Petros Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience // Clinical genitourinary cancer, 21 (2023), 5; 584-593. doi: 10.1016/j.clgc.2023.06.008
Murgić, Jure ; Fröbe, Ana Artificial intelligence, active surveillance and treatment of localized prostate cancer // Libri oncologici : Croatian journal of oncology. 2023. str. 6-8
Murgić, Jure ; Gregov, Marin ; Mrčela, Iva ; Budanec, Mirjana ; Krengli, Marco ; Fröbe, Ana ; Franco, Pierfrancesco MRI-Guided Radiotherapy for Prostate Cancer: a New Paradigm // Acta clinica Croatica, 61 (2022), Suppl. 3; 65-70. doi: 10.20471/acc.2022.61.s3.9
Mrčela, Iva ; Gregov, Marin ; Budanec, Mirjana ; Murgić, Jure ; Jakšić, Blanka ; Prpić, Marin ; Prgomet Sečan, Angela ; Fröbe, Ana Dosimetric verification of intensity modulated radiotherapy (IMRT) treatment plans for prostate cancer patients // Acta clinica Croatica, 61 (2022), Supplement 3; 21-27. doi: 10.20471/acc.2022.61.s3.3
Ljubić, Sven ; Sermek, Antonio ; Prgomet Sečan, Angela ; Prpić, Marin ; Jakšić, Blanka ; Murgić, Jure ; Fröbe, Ana ; Ugarković, Đurđica ; Feliciello, Isidoro Alpha Satellite RNA Levels Are Upregulated in the Blood of Patients with Metastatic Castration- Resistant Prostate Cancer // Genes, 13 (2022), 2; 383, 12. doi: 10.3390/genes13020383
Murgić, Jure ; Fröbe, Ana ; Kiang Chua, Melvin Lee Recent Advances in Radiotherapy Modalities for Prostate Cancer // Acta clinica Croatica, 61 (2022), Supplement 3; 57-63. doi: 10.20471/acc.2022.61.s3.8
nije evidentirano
nije evidentirano